Gemfibrozil reduced the risk for stroke in men with coronary heart disease and low concentrations of high-density lipoprotein cholesterol

Gemfibrozil v placebo for preventing strokes in men with coronary artery disease and low high-density lipoprotein cholesterol at mean 5.1 years¶

Outcome	Gemfibrozil	Placebo	Adjusted RRR (95% CI)**	NNT (CI)
¶Abbreviations defined in glossary; NNT and CI provided by author.
**Adjusted for baseline variables.
All strokes	4.6%	6.0%	31% (2 to 52)	55 (33 to 688)

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from the blog